Literature DB >> 16951157

Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers.

Jairo Rodriguez1, Jordi Frigola, Elisenda Vendrell, Rosa-Ana Risques, Mario F Fraga, Cristina Morales, Victor Moreno, Manel Esteller, Gabriel Capellà, Maria Ribas, Miguel A Peinado.   

Abstract

DNA hypomethylation is a common trait of colorectal cancer. Studies in tumor cell lines and animal models indicate that genome-wide demethylation may cause genetic instability and hence facilitate or accelerate tumor progression. Recent studies have shown that DNA hypomethylation precedes genomic damage in human gastrointestinal cancer, but the nature of this damage has not been clearly established. Here, we show a thorough analysis of DNA methylation and genetic alterations in two series of colorectal carcinomas. The extent of DNA demethylation but not of hypermethylation (both analyzed by amplification of intermethylated sites in near 200 independent sequences arbitrarily selected) correlated with the cumulated genomic damage assessed by two different techniques (arbitrarily primed PCR and comparative genomic hybridization). DNA hypomethylation-related instability was mainly of chromosomal nature and could be explained by a genome-wide effect rather than by the concurrence of the most prevalent genetic and epigenetic alterations. Moreover, the association of p53 mutations with genomic instability was secondary to DNA hypomethylation and the correlation between DNA hypomethylation and genomic instability was observed in tumors with and without mutation in the p53 gene. Our data support a direct link between genome-wide demethylation and chromosomal instability in human colorectal carcinogenesis and are consistent with the studies in model systems demonstrating a role of DNA demethylation in inducing chromosomal instability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951157     DOI: 10.1158/0008-5472.CAN-06-0293

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  120 in total

Review 1.  Colorectal cancer molecular biology moves into clinical practice.

Authors:  Colin C Pritchard; William M Grady
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

2.  Genome-wide Profiling Identifies DNA Methylation Signatures of Aging in Rod Photoreceptors Associated with Alterations in Energy Metabolism.

Authors:  Ximena Corso-Díaz; James Gentry; Ryan Rebernick; Catherine Jaeger; Matthew J Brooks; Freekje van Asten; Keshav Kooragayala; Linn Gieser; Jacob Nellissery; Raul Covian; Tiziana Cogliati; Anupam K Mondal; Ke Jiang; Anand Swaroop
Journal:  Cell Rep       Date:  2020-04-21       Impact factor: 9.423

3.  A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide.

Authors:  Z Ji; L Zhang; V Peng; X Ren; C M McHale; M T Smith
Journal:  Leukemia       Date:  2010-03-25       Impact factor: 11.528

Review 4.  Epigenetic alterations in inflammatory bowel disease and cancer.

Authors:  Joo Mi Yi; Tae Oh Kim
Journal:  Intest Res       Date:  2015-04-27

Review 5.  Molecular alterations and biomarkers in colorectal cancer.

Authors:  William M Grady; Colin C Pritchard
Journal:  Toxicol Pathol       Date:  2013-10-31       Impact factor: 1.902

6.  Maternal B vitamin supplementation from preconception through weaning suppresses intestinal tumorigenesis in Apc1638N mouse offspring.

Authors:  Eric D Ciappio; Zhenhua Liu; Ryan S Brooks; Joel B Mason; Roderick T Bronson; Jimmy W Crott
Journal:  Gut       Date:  2011-06-09       Impact factor: 23.059

Review 7.  DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.

Authors:  Yutaka Hashimoto; Timothy J Zumwalt; Ajay Goel
Journal:  Epigenomics       Date:  2016-04-22       Impact factor: 4.778

8.  CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.

Authors:  Yu-Wei Cheng; Hanna Pincas; Manny D Bacolod; Gunter Schemmann; Sarah F Giardina; Jianmin Huang; Sandra Barral; Kamran Idrees; Sajid A Khan; Zhaoshi Zeng; Shoshana Rosenberg; Daniel A Notterman; Jurg Ott; Philip Paty; Francis Barany
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

Review 9.  Promoter methylation in the genesis of gastrointestinal cancer.

Authors:  Clement Richard Boland; Sung Kwan Shin; Ajay Goel
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

10.  ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma.

Authors:  Silke Götze; Valeska Feldhaus; Thilo Traska; Marietta Wolter; Guido Reifenberger; Andrea Tannapfel; Cornelius Kuhnen; Dirk Martin; Oliver Müller; Sonja Sievers
Journal:  BMC Cancer       Date:  2009-12-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.